Results 41 to 50 of about 16,205 (225)
Efficacy of Acellular Pertussis Vaccine
Journal of the Japanese Association for Infectious Diseases, 1990 An outbreak of pertussis occurred in one room of a residential facility where 19 children aged 5 to 36 months were residing. They were prospectively surveyed to estimate the efficacy of acellular pertussis vaccine. Among the 19 residents, 9 were immunized with acellular pertussis vaccine.
T, Saito +7 more
openaire +3 more sources
Replacement, Reduction and Refinement of Animal Testing in the Quality Control of Human Vaccines [PDF]
, 2015 Vaccines are recognised as a highly cost effective tool for preventing infectious diseases. They are derived from biological sources and due to the complexity of composition and heterogeneity of products, vaccine lots undergo legally required quality ...
HALDER MARIA ELISABETH
core +1 more source
Vaccinations During Pregnancy Protect the Mother–Infant Dyad and Are Generally Safe
Acta Paediatrica, EarlyView.ABSTRACT Aim Vaccination in pregnancy has a critical impact on mothers, foetuses and infants. The aim of this paper was to summarise key points presented by experts attending the 12th Maria Delivoria‐Papadopoulos Perinatal Symposium in March 2025 and further expand and update them.
Ariadne Malamitsi‐Puchner +2 more
wiley +1 more source
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity
Vaccines, 2022 After the pertussis vaccine had been introduced in the 1940s and was shown to be very successful in reducing the morbidity and mortality associated with the disease, the possibility of improving both vaccine composition and vaccination schedules has ...
Ewa Szwejser-Zawislak +5 more
doaj +1 more source
Immune persistence after pertussis vaccination
Human Vaccines & Immunotherapeutics, 2017 Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true infection rate is significantly higher than the reported incidence rate.
Zhiyun Chen, Qiushui He
doaj +1 more source
Acellular Pertussis Vaccine Effectiveness Over Time [PDF]
Pediatrics, 2019 To determine pertussis risk by diphtheria-tetanus-acellular pertussis (DTaP) vaccination status and time since last DTaP dose.Children born at Kaiser Permanente Northern California between 1999 and 2016 were followed from 3 months of age until they tested positive for pertussis; disenrolled from Kaiser Permanente Northern California; received the ...
Ousseny, Zerbo +5 more
openaire +2 more sources
Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England. [PDF]
, 2016 : Maternal pertussis immunisation was introduced during the pertussis resurgence in England in 2012 as a temporary measure to protect infants too young to be vaccinated. The programme was shown to be safe and highly effective.
Amirthalingam, G +4 more
core +2 more sources
The Update, March 22, 2010 [PDF]
, 2010 The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...
core
Enhanced Bordetella pertussisacquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection. [PDF]
, 2017 IntroductionIn 2012 a large epidemic of pertussis occurred in the Netherlands. We assessed pertussis toxin (PT) antibody levels in longitudinal serum samples from Dutch 10-18 year-olds, encompassing the epidemic, to investigate pertussis infection ...
Berbers, Guy A M +7 more
core +2 more sources
Defining the tumor microenvironment of non‐small cell lung cancer
Immunology &Cell Biology, EarlyView.The tumor microenvironment (TME) in non‐small cell lung cancer is highly heterogeneous, both at a patient level and tumor microenvironment resolution. Defining the tumor microenvironment from patient‐responders and non‐responders will aid in the development of targeted therapeutics specific for each individual patient.
Kidane Siele Embaye +5 more
wiley +1 more source